LexaGene Holdings Inc. LXXGF Archives - Page 2 of 2

TuesdayDec 15, 2020 11:20 am

QualityStocksNewsBreaks – LexaGene (TSX.V: LXG) (OTCQB: LXXGF) Announces PO from Ethos Discovery for Proprietary MiQLab

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, received a purchase order (“PO”) from Ethos Discovery for its exclusive MiQLab(TM). Designed for use in veterinary hospitals, MiQLab features an automated, easy-to-use system and rapid, in-hospital identification of pathogens. That information is invaluable for veterinarians as they make patient-care decisions. LexaGene’s MiQLab tests samples using real-time PCR, which is recognized for its sensitivity and specificity. “Up until now, veterinarians have had limited options for infectious disease testing,” said LexaGene CEO and founder Jack Regan, MD, in the press release. “Generally, veterinarians send collected…

WednesdayDec 09, 2020 1:00 pm

QualityStocksNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) to Participate at LD Micro Main Event

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that Dr. Jack Regan, LexaGene’s CEO and founder, will present at the 13th Annual LD Micro Main Event Conference. Interested parties should visit https://ibn.fm/tKpNj to register for the event, slated to be held on Dec. 15, 2020. In addition, the company announced that it has engaged Native Ads Inc. of New York to perform strategic digital media, marketing and data analytics services including, but not limited to, content development, video production and editing, website development, media buying and distribution, and campaign…

WednesdayNov 18, 2020 10:37 am

QualityStocksNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Places MiQLab(TM) System in Penn Vet Microbiology Laboratory

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that it has placed a MiQLab(TM) system into the clinical microbiology laboratory at the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet) as part of its Early Access Program. Penn Vet provides animal patient testing at the Ryan Veterinary Hospital and for patients of practices across the United States, processing thousands of samples each year. “We are very excited to be placing our first completed commercial MiQLab system in the Penn Vet microbiology laboratory for their evaluation,” said Dr.…

MondayNov 16, 2020 10:47 am

QualityStocksNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Announces Annual General Shareholder’s Meeting Results, Secures Order for MiQLab(TM) System

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, on Friday announced the voting results of the company’s 2020 Annual General Shareholder’s Meeting held on November 10, 2020 in Vancouver, British Columbia. According to the update, a total of 48,273,080 common shares were voted at the meeting, representing 42.26% of the votes attached to all outstanding common shares of the company. All matters presented for shareholder approval at the meeting were duly authorized and approved. In addition, LexaGene today announced its receipt of a purchase order for a MiQLab(TM) system from…

TuesdayNov 10, 2020 10:41 am

QualityStocksNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Selected to Present at Upcoming Investor Conferences

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is slated to present at two upcoming investor conferences. Representing LexaGene at the conferences will be founder and CEO Jack Regan. Regan will be a presenter at the Investor Summit Group Conference held Nov. 18, 2020, at 1:30 p.m. and at the Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum scheduled for Nov. 19, 2020, at 10 a.m. EST; additional information about these conferences and Regan’s presentations is available on the event page of LexaGene’s website.“This is an excellent opportunity for the Company…

MondayOct 05, 2020 11:46 am

QualityStocksNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Issues Corporate Update

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today provided a general corporate update. Among highlights provided in the update, LexaGene is in a strong position to support its development goals for the next year and beyond with its treasury currently standing at US$11.3 million (C$14.9 million). “Our MiQLab(TM) pathogen detection system has 230 unique components. Over the summer, the coronavirus pandemic caused some supply chain issues for several key components that delayed the manufacturing, optimization and testing of these systems. Just recently, these supply chain issues were resolved and…

MondaySep 21, 2020 11:10 am

QualityStocksNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Announces Engagement of Tailwinds Research Group, Video Update and Strategic Advisory Board Appointment

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, on Friday announced its engagement of Tailwinds Research Group to provide digital content distribution for the company. According to the update, the engagement will cover a 1-year term, at US$2,500/month with 100,000 stock options provided at C$0.88/option. In addition, LexaGene today released a video message from its founder and CEO, Dr. Jack Regan, that highlighted the company’s progress toward commercial sales and announced the appointment of Dr. Shelley Rankin to LexaGene’s Scientific Advisory Board. “As we approach sales, I’m very pleased to…

Site Search

Company Search

Tag: LexaGene Holdings Inc. LXXGF